Imaflex Ptb Ratio vs Price To Sales Ratio Analysis

IFX Stock

CAD 1.26 0.01 0.80%

Imaflex financial indicator trend analysis is infinitely more than just investigating Imaflex recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Imaflex is a good investment. Please check the relationship between Imaflex Ptb Ratio and its Price To Sales Ratio accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Imaflex. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Ptb Ratio vs Price To Sales Ratio

Ptb Ratio vs Price To Sales Ratio Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Imaflex Ptb Ratio account and Price To Sales Ratio. At this time, the significance of the direction appears to have strong relationship.

The correlation between Imaflex's Ptb Ratio and Price To Sales Ratio is 0.76. Overlapping area represents the amount of variation of Ptb Ratio that can explain the historical movement of Price To Sales Ratio in the same time period over historical financial statements of Imaflex, assuming nothing else is changed. The correlation between historical values of Imaflex's Ptb Ratio and Price To Sales Ratio is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Ptb Ratio of Imaflex are associated (or correlated) with its Price To Sales Ratio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Price To Sales Ratio has no effect on the direction of Ptb Ratio i.e., Imaflex's Ptb Ratio and Price To Sales Ratio go up and down completely randomly.

Correlation Coefficient

0.76

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Ptb Ratio

Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Imaflex stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Imaflex sales, a figure that is much harder to manipulate than other Imaflex multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Most indicators from Imaflex's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Imaflex current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Imaflex. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

At this time, Imaflex's Enterprise Value Over EBITDA is fairly stable compared to the past year. Enterprise Value Multiple is likely to climb to 8.69 in 2025, whereas Selling General Administrative is likely to drop slightly above 5.2 M in 2025.

	2022	2023	2024	2025 (projected)
Interest Expense	449.4K	593.9K	683.0K	610.3K
Depreciation And Amortization	4.1M	4.6M	5.3M	5.6M

Interest Expense Depreciation And Amortization

Imaflex fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Net Receivables	Cash	Current Deferred Revenue	Other Liab	Net Tangible Assets
Total Assets		0.46	0.47	0.28	0.98	0.97	0.15	0.95	0.34	0.97	0.16	0.24	0.73	-0.67	0.88	0.68	0.71	-0.44	0.66	0.68	0.06	0.7	0.32	0.41	0.68	0.81
Short Long Term Debt Total	0.46		0.29	0.79	0.31	0.39	0.83	0.2	0.67	0.37	-0.05	-0.34	0.72	-0.12	0.47	0.7	0.47	-0.24	0.87	0.54	0.68	0.69	-0.22	0.65	0.06	0.2
Other Current Liab	0.47	0.29		0.23	0.5	0.32	-0.13	0.45	0.12	0.3	-0.54	0.53	0.72	0.08	0.25	0.77	0.54	-0.58	0.39	0.8	-0.06	0.67	0.58	0.64	0.27	0.6
Total Current Liabilities	0.28	0.79	0.23		0.14	0.18	0.65	0.04	0.86	0.17	-0.01	-0.3	0.6	0.0	0.11	0.61	0.31	-0.08	0.77	0.51	0.91	0.67	-0.17	0.57	0.1	0.04
Total Stockholder Equity	0.98	0.31	0.5	0.14		0.96	-0.03	0.99	0.19	0.95	0.11	0.38	0.68	-0.64	0.83	0.63	0.66	-0.41	0.54	0.68	-0.08	0.65	0.44	0.35	0.72	0.87
Property Plant And Equipment Net	0.97	0.39	0.32	0.18	0.96		0.17	0.95	0.26	1.0	0.31	0.14	0.63	-0.73	0.91	0.53	0.67	-0.42	0.6	0.53	0.0	0.57	0.2	0.32	0.73	0.79
Net Debt	0.15	0.83	-0.13	0.65	-0.03	0.17		-0.12	0.62	0.17	0.28	-0.81	0.36	-0.13	0.36	0.29	0.32	-0.16	0.68	0.05	0.66	0.33	-0.73	0.35	-0.09	-0.16
Retained Earnings	0.95	0.2	0.45	0.04	0.99	0.95	-0.12		0.09	0.94	0.14	0.42	0.6	-0.64	0.8	0.55	0.6	-0.38	0.45	0.62	-0.16	0.58	0.47	0.26	0.75	0.89
Accounts Payable	0.34	0.67	0.12	0.86	0.19	0.26	0.62	0.09		0.27	0.2	-0.37	0.54	-0.15	0.3	0.54	0.35	-0.21	0.79	0.42	0.65	0.61	-0.26	0.45	0.15	0.07
Non Current Assets Total	0.97	0.37	0.3	0.17	0.95	1.0	0.17	0.94	0.27		0.34	0.11	0.61	-0.74	0.92	0.51	0.67	-0.44	0.6	0.5	-0.01	0.55	0.17	0.3	0.73	0.78
Non Currrent Assets Other	0.16	-0.05	-0.54	-0.01	0.11	0.31	0.28	0.14	0.2	0.34		-0.52	-0.23	-0.48	0.36	-0.31	0.11	-0.06	0.14	-0.4	0.06	-0.2	-0.54	-0.27	0.29	-0.03
Cash And Short Term Investments	0.24	-0.34	0.53	-0.3	0.38	0.14	-0.81	0.42	-0.37	0.11	-0.52		0.15	0.06	-0.07	0.24	-0.05	-0.04	-0.24	0.48	-0.43	0.17	0.99	0.08	0.21	0.49
Common Stock Shares Outstanding	0.73	0.72	0.72	0.6	0.68	0.63	0.36	0.6	0.54	0.61	-0.23	0.15		-0.15	0.58	0.94	0.68	-0.39	0.86	0.89	0.31	0.93	0.26	0.79	0.5	0.71
Short Term Investments	-0.67	-0.12	0.08	0.0	-0.64	-0.73	-0.13	-0.64	-0.15	-0.74	-0.48	0.06	-0.15		-0.71	-0.04	-0.47	0.3	-0.2	-0.04	0.05	-0.12	0.05	0.1	-0.33	-0.27
Non Current Liabilities Total	0.88	0.47	0.25	0.11	0.83	0.91	0.36	0.8	0.3	0.92	0.36	-0.07	0.58	-0.71		0.49	0.7	-0.54	0.63	0.41	-0.1	0.5	-0.02	0.33	0.53	0.65
Inventory	0.68	0.7	0.77	0.61	0.63	0.53	0.29	0.55	0.54	0.51	-0.31	0.24	0.94	-0.04	0.49		0.62	-0.36	0.82	0.96	0.32	0.98	0.35	0.74	0.42	0.69
Other Current Assets	0.71	0.47	0.54	0.31	0.66	0.67	0.32	0.6	0.35	0.67	0.11	-0.05	0.68	-0.47	0.7	0.62		-0.52	0.6	0.53	0.07	0.59	0.02	0.5	0.42	0.51
Other Stockholder Equity	-0.44	-0.24	-0.58	-0.08	-0.41	-0.42	-0.16	-0.38	-0.21	-0.44	-0.06	-0.04	-0.39	0.3	-0.54	-0.36	-0.52		-0.38	-0.28	0.15	-0.3	-0.03	-0.39	-0.24	-0.36
Total Liab	0.66	0.87	0.39	0.77	0.54	0.6	0.68	0.45	0.79	0.6	0.14	-0.24	0.86	-0.2	0.63	0.82	0.6	-0.38		0.69	0.55	0.85	-0.12	0.71	0.46	0.51
Total Current Assets	0.68	0.54	0.8	0.51	0.68	0.53	0.05	0.62	0.42	0.5	-0.4	0.48	0.89	-0.04	0.41	0.96	0.53	-0.28	0.69		0.23	0.94	0.58	0.68	0.45	0.74
Short Term Debt	0.06	0.68	-0.06	0.91	-0.08	0.0	0.66	-0.16	0.65	-0.01	0.06	-0.43	0.31	0.05	-0.1	0.32	0.07	0.15	0.55	0.23		0.41	-0.32	0.32	-0.04	-0.19
Net Receivables	0.7	0.69	0.67	0.67	0.65	0.57	0.33	0.58	0.61	0.55	-0.2	0.17	0.93	-0.12	0.5	0.98	0.59	-0.3	0.85	0.94	0.41		0.28	0.67	0.47	0.68
Cash	0.32	-0.22	0.58	-0.17	0.44	0.2	-0.73	0.47	-0.26	0.17	-0.54	0.99	0.26	0.05	-0.02	0.35	0.02	-0.03	-0.12	0.58	-0.32	0.28		0.18	0.22	0.53
Current Deferred Revenue	0.41	0.65	0.64	0.57	0.35	0.32	0.35	0.26	0.45	0.3	-0.27	0.08	0.79	0.1	0.33	0.74	0.5	-0.39	0.71	0.68	0.32	0.67	0.18		0.23	0.4
Other Liab	0.68	0.06	0.27	0.1	0.72	0.73	-0.09	0.75	0.15	0.73	0.29	0.21	0.5	-0.33	0.53	0.42	0.42	-0.24	0.46	0.45	-0.04	0.47	0.22	0.23		0.84
Net Tangible Assets	0.81	0.2	0.6	0.04	0.87	0.79	-0.16	0.89	0.07	0.78	-0.03	0.49	0.71	-0.27	0.65	0.69	0.51	-0.36	0.51	0.74	-0.19	0.68	0.53	0.4	0.84

Click cells to compare fundamentals

Imaflex Account Relationship Matchups

Imaflex fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	54.1M	65.0M	72.0M	83.5M	96.0M	100.8M
Short Long Term Debt Total	9.8M	9.6M	8.0M	11.4M	13.1M	10.9M
Other Current Liab	3.2M	3.3M	3.3M	2.1M	2.5M	1.4M
Total Current Liabilities	9.8M	14.3M	11.8M	14.4M	16.6M	12.9M
Total Stockholder Equity	36.0M	45.1M	55.1M	55.9M	64.2M	67.4M
Property Plant And Equipment Net	25.9M	24.5M	37.8M	47.8M	54.9M	57.7M
Net Debt	6.6M	1.1M	502.8K	10.6M	12.2M	9.7M
Retained Earnings	21.9M	30.3M	39.4M	39.9M	45.9M	48.2M
Accounts Payable	3.9M	5.6M	3.4M	6.4M	7.3M	5.6M
Non Current Assets Total	27.4M	26.3M	40.0M	55.1M	63.3M	66.5M
Non Currrent Assets Other	(1.5M)	(3.3M)	(3.4M)	1.8M	1.6M	1.7M
Cash And Short Term Investments	3.2M	8.5M	7.5M	799.1K	919.0K	1.5M
Common Stock Shares Outstanding	50.7M	51.6M	51.9M	52.0M	59.8M	45.7M
Liabilities And Stockholders Equity	54.1M	65.0M	72.0M	83.5M	96.0M	100.8M
Non Current Liabilities Total	8.3M	5.6M	5.1M	13.2M	15.2M	15.9M
Inventory	11.7M	14.9M	12.2M	13.2M	15.1M	8.7M
Other Current Assets	238.9K	204.8K	235.6K	343.2K	394.6K	414.4K
Other Stockholder Equity	1.7M	2.2M	3.1M	1.0	0.9	0.86
Total Liab	18.1M	19.9M	16.8M	27.6M	31.8M	19.7M
Total Current Assets	26.6M	38.7M	32.0M	28.4M	32.7M	20.2M
Short Term Debt	2.7M	5.3M	5.1M	5.9M	6.8M	5.9M
Net Receivables	11.5M	15.1M	12.1M	14.1M	16.2M	10.5M
Cash	3.2M	8.5M	7.5M	799.1K	919.0K	1.5M
Accumulated Other Comprehensive Income	484.6K	2.2M	3.1M	3.0M	3.4M	3.6M
Other Liab	1.2M	1.2M	1.4M	2.1M	2.4M	1.5M
Net Tangible Assets	28.5M	34.4M	43.3M	52.9M	60.9M	30.7M
Good Will	478.0K	476.0K	508.5K	496.6K	571.1K	528.9K
Short Long Term Debt	1.9M	4.5M	4.2M	4.2M	3.8M	4.2M
Intangible Assets	1.1M	1.3M	1.7M	1.8M	2.0M	1.2M
Common Stock	11.9M	12.6M	12.6M	12.9M	14.9M	12.9M
Property Plant Equipment	28.6M	25.9M	24.5M	37.8M	43.4M	25.1M
Long Term Debt	6.4M	5.5M	3.5M	1.7M	1.6M	1.5M
Capital Lease Obligations	2.4M	1.6M	2.1M	7.2M	8.3M	8.7M
Net Invested Capital	43.4M	53.1M	61.0M	60.1M	69.1M	52.7M
Net Working Capital	16.8M	24.4M	20.3M	14.0M	16.1M	16.6M
Capital Stock	11.9M	12.6M	12.6M	12.9M	14.9M	13.5M
Property Plant And Equipment Gross	68.6M	71.0M	89.5M	99.9M	114.9M	87.4M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Imaflex Stock Analysis

When running Imaflex's price analysis, check to measure Imaflex's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Imaflex is operating at the current time. Most of Imaflex's value examination focuses on studying past and present price action to predict the probability of Imaflex's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Imaflex's price. Additionally, you may evaluate how the addition of Imaflex to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC